Associations of genetic polymorphisms of SAA1 with cerebral infarction

Background Serum amyloid A protein (SAA) is both an inflammatory factor and an apolipoprotein. However, the relation between genetic polymorphisms of SAA and cerebral infarction (CI) remains unclear. Methods and results The previously reported 4 Single Nucleotide Polymorphisms (rs12218, rs4638289, r...

Full description

Saved in:
Bibliographic Details
Published inLipids in health and disease Vol. 12; no. 1; p. 130
Main Authors Zhang, Li-Jun, Yuan, Bin, Li, He-Hua, Tao, Sheng-Bo, Yan, Hai-Qing, Chang, Li, Zhao, Jian-Hua
Format Journal Article
LanguageEnglish
Published London BioMed Central 29.08.2013
BioMed Central Ltd
Subjects
Online AccessGet full text
ISSN1476-511X
1476-511X
DOI10.1186/1476-511X-12-130

Cover

More Information
Summary:Background Serum amyloid A protein (SAA) is both an inflammatory factor and an apolipoprotein. However, the relation between genetic polymorphisms of SAA and cerebral infarction (CI) remains unclear. Methods and results The previously reported 4 Single Nucleotide Polymorphisms (rs12218, rs4638289, rs7131332, and rs11603089) of SAA1 gene were genotyped by TaqMan method in a case–control study including 287 cerebral infarction patients and 376 control subjects. We found rs12218 CC genotype and rs7131332 AA genotype were more frequent among CI patients than among controls (9.76% versus 3.19%, P = 0.001; 32.75% versus 24.20%; p = 0.017; respectively). After adjustment of confounding factors such as sex, age, smoking, drinking, hypertension, diabetes, and lipids profile, the difference remained significant in rs12218 (P < 0.01, OR = 2.106, 95% CI: 1.811–7.121). Conclusion Genetic polymorphism of SAA1 may be a genetic maker of cerebral infarction in Chinese.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1476-511X
1476-511X
DOI:10.1186/1476-511X-12-130